EU agency says weight-loss drugs risk acceptable

LONDON (Reuters) - The European Medicines Agency has decided that the benefits of orlistat-containing weight loss drugs, including GlaxoSmithKline's Alli and Roche's Xenical, outweigh the risk of very rare liver-related side effects.

Related Stories

• Student jailed for "extensive" Facebook hack
• MP presses UK to rule out force against Iran
• Star factory shines at London Fashion Week
• Judi Dench says sight failing
• UK must not lose lead in marine renewables drive

Source: http://uk.reuters.com/article/2012/02/16/uk-eu-agency-weight-loss-idUKTRE81F29320120216?feedType=RSS&feedName=domesticNews

beauty computers technology pets